Prolonged prophylaxis in orthopedic surgery: insights from the United States
UMass Chan Affiliations
Center for Outcomes ResearchDocument Type
Journal ArticlePublication Date
2002-08-17Keywords
Aged*Arthroplasty, Replacement, Hip
*Arthroplasty, Replacement, Knee
Bandages
Combined Modality Therapy
Drug Utilization
Female
Fibrinolytic Agents
Heparin, Low-Molecular-Weight
Humans
Male
Middle Aged
Postoperative Complications
Postoperative Period
Pulmonary Embolism
Registries
Thrombosis
United States
Health Services Research
Orthopedics
Metadata
Show full item recordAbstract
The U.S. Hip and Knee Registry is a voluntary national registry of outcome data for hip and knee surgery. In total, 469 orthopedic surgeons from 325 hospitals reported data on 7677 patients who underwent total hip arthroplasty (THA) and 11,461 patients who underwent total knee arthroplasty (TKA). Data on patients enrolled between 1996 and 2000 indicate that 40% of THA patients and 42% of TKA patients received prophylaxis for a period of 8 to 21 days, including the in-hospital period. Prolonged prophylaxis for more than 21 days was used in 49% of THA patients and 44% of TKA patients. Moreover, year on year, data indicate that the percentage of patients who receive prophylaxis for longer than 21 days is gradually increasing. In 2000, 53% of THA patients and 47% of TKA patients received prophylaxis for longer than 21 days.Source
Semin Thromb Hemost. 2002 Aug;28 Suppl 3:43-6. Link to article on publisher's siteDOI
10.1055/s-2002-34075Permanent Link to this Item
http://hdl.handle.net/20.500.14038/27297PubMed ID
12232823Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1055/s-2002-34075